BioWin and Polepharma sign a partnership agreement to strengthen collaboration in the biopharmaceutical sector.
The two clusters officially launched their partnership
at the 8th BioWin Day.
Namur, Belgium and Chartre, France, 18 October 2023 – BioWin, the health cluster of Wallonia, and Polepharma, the French (bio)pharmaceutical industry cluster, have formalised their partnership aimed at strengthening collaboration between the two entities. The agreement focuses on three key areas: human resources, biomanufacturing and biomedical research projects.
For Sylvie Ponchaut, Managing Director of BioWin,
This partnership marks an important step in the development of relations between the Walloon and French biopharmaceutical ecosystems. The collaboration between our two regions will provide a wealth of knowledge and skills essential to the continued growth of this sector, to the benefit of the members of our respective structures.
Fabien Riolet, Managing Director of Polepharma, added:
Our strategic partnership with BioWin reinforces our commitment to innovation and growth in the biopharmaceutical industry. Together, we intend to promote the cross-fertilisation of our ecosystems for the benefit of our respective members and, in so doing, strengthen our countries’ position in biomanufacturing and biotech innovation.
This agreement opens up new prospects for the biopharmaceutical sector in France and Belgium, promoting the sharing of knowledge, employment and innovation.
Press contact:
For BioWin:
Alexandra Schiettekatte
+32 476 650 438
alexandra.schiettekatte@biowin.org
Press contact:
For Polepharma:
Sabrina Boireau
+32 37 20 77 19
sabrina.boireau@polepharma.com
About BioWin
BioWin is the health cluster in Wallonia, Belgium, the regional reference for all stakeholders in health, biotech and medtech research, and innovation projects. It includes 250 members from the private, public and academic sectors.
Biowin’s mission is to accelerate innovation to meet tomorrow’s public health challenges and develop the knowledge, employment and competitiveness of all players in the health sector ecosystem. By bringing together all the innovation players in Wallonia’s life sciences field, BioWin aims to stimulate regional economic redeployment. The cluster is also involved in implementing the sector’s industrial policy (industrial innovation and research, training, support for business growth), to develop and anchor skills, knowledge and jobs.
www.biowin.org
About Polepharma
Polepharma, the French (bio)pharmaceutical industrial sector
Polepharma has become the top industrial cooperation for drugs in Europe, between centres of excellence and the stakeholders in the sector : 445+ members in all of France, 26 billion in export sales, 80k jobs throughout the entire sector, 5 offices (Chartres, Louviers, Tours, Paris, Bordeaux).
One of France’s priority is to ensure its health sovereignty. To achieve this, our country has to regain its European leadership and accelerate the transition of its (bio)pharmaceutical industry. Only a coordinated response will take on these challenges. Polepharma has been structuring the French (bio)pharmaceutical industrial sector and supporting its transformation for 20 years now.
Polepharma’s action is guided by three collective values :
Audacity : The audacity to make France the best place in the world to develop & produce drugs
Pride : The pride of manufacturing high quality treatments in France in the best conditions and to secure public health, to contribute to employment and the local economies
Cooperation : Our rationale for 20 years : industrial cooperation between territories and pharmaceutical laboratories, suppliers, higher education and training institutes, experts, talents
https://www.polepharma.com/
